PA
Profund Advisors Portfolio holdings
AUM
$2.78B
This Quarter Return
+14.4%
1 Year Return
+29.53%
3 Year Return
+153.44%
5 Year Return
+262.59%
10 Year Return
+738.89%
AUM
$1.62B
AUM Growth
+$1.62B
(+5%)
Cap. Flow
-$73.1M
Cap. Flow
% of AUM
-4.52%
Top 10 Holdings %
Top 10 Hldgs %
28.88%
Holding
1,192
New
188
Increased
323
Reduced
578
Closed
103
Top Buys
| 1 |
NVIDIA
NVDA
|
$4.03M |
| 2 |
Broadcom
AVGO
|
$3.21M |
| 3 |
Tesla
TSLA
|
$2.65M |
| 4 |
Viking Therapeutics
VKTX
|
$1.64M |
| 5 |
Texas Instruments
TXN
|
$1.6M |
Top Sells
| 1 |
AbbVie
ABBV
|
$27.3M |
| 2 |
Danaher
DHR
|
$16.8M |
| 3 |
Amgen
AMGN
|
$12.2M |
| 4 |
Gilead Sciences
GILD
|
$9.54M |
| 5 |
Regeneron Pharmaceuticals
REGN
|
$7.75M |
Sector Composition
| 1 | Technology | 33.28% |
| 2 | Healthcare | 16.86% |
| 3 | Consumer Discretionary | 11.45% |
| 4 | Communication Services | 8.63% |
| 5 | Energy | 7.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
176
Trip.com Group
TCOM
$46.6B
| $1.57M | 0.1% |
41,625
-810
| -2% | -$30.5K |
|
177
United Therapeutics
UTHR
$17.7B
| $1.56M | 0.1% |
6,967
+383
| +6% | +$85.8K |
|
178
Verisk Analytics
VRSK
$37.5B
| $1.56M | 0.1% |
8,124
-322
| -4% | -$61.8K |
|
179
TJX Companies
TJX
$155B
| $1.55M | 0.1% |
19,801
+2,391
| +14% | +$187K |
|
180
Philip Morris
PM
$254B
| $1.55M | 0.1% |
15,904
-1,188
| -7% | -$116K |
|
181
Consolidated Edison
ED
$35.3B
| $1.54M | 0.1% |
16,114
-902
| -5% | -$86.3K |
|
182
RTX Corp
RTX
$212B
| $1.53M | 0.09% |
15,648
-702
| -4% | -$68.7K |
|
183
United Parcel Service
UPS
$72.3B
| $1.51M | 0.09% |
7,795
-320
| -4% | -$62.1K |
|
184
Catalyst Pharmaceutical
CPRX
$2.42B
| $1.49M | 0.09% |
90,134
+77,524
| +615% | +$1.29M |
|
185
American Tower
AMT
$91.9B
| $1.49M | 0.09% |
7,298
-1,701
| -19% | -$348K |
|
186
Veeva Systems
VEEV
$44.4B
| $1.48M | 0.09% |
8,074
-704
| -8% | -$129K |
|
187
CoStar Group
CSGP
$37.2B
| $1.48M | 0.09% |
21,440
-3,843
| -15% | -$265K |
|
|
ISEE
188
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $1.46M | 0.09% |
+60,003
| New | +$1.46M |
|
189
Fate Therapeutics
FATE
$115M
| $1.45M | 0.09% |
254,989
+243,798
| +2,179% | +$1.39M |
|
190
Incyte
INCY
$17B
| $1.45M | 0.09% |
20,056
-1,587
| -7% | -$115K |
|
191
Stryker
SYK
$149B
| $1.45M | 0.09% |
5,071
-731
| -13% | -$209K |
|
192
CVS Health
CVS
$93B
| $1.44M | 0.09% |
19,317
-3,302
| -15% | -$245K |
|
193
Apellis Pharmaceuticals
APLS
$3.51B
| $1.43M | 0.09% |
21,694
+8,972
| +71% | +$592K |
|
194
Align Technology
ALGN
$9.59B
| $1.43M | 0.09% |
4,270
-379
| -8% | -$127K |
|
195
PTC Therapeutics
PTCT
$4.41B
| $1.42M | 0.09% |
+29,321
| New | +$1.42M |
|
196
Arcus Biosciences
RCUS
$1.24B
| $1.42M | 0.09% |
+77,772
| New | +$1.42M |
|
197
Public Service Enterprise Group
PEG
$40.6B
| $1.42M | 0.09% |
22,666
-1,265
| -5% | -$79K |
|
198
Halozyme
HALO
$8.75B
| $1.41M | 0.09% |
36,928
+14,216
| +63% | +$543K |
|
199
Cytokinetics
CYTK
$5.98B
| $1.41M | 0.09% |
40,074
+34,405
| +607% | +$1.21M |
|
200
Alkermes
ALKS
$4.95B
| $1.4M | 0.09% |
49,633
+27,417
| +123% | +$773K |
|